Back to discover
Disease

Leukopenia

Late-stage therapeutic developmentEmerging research
MeSHLeukopenia
2
Publications
5
Clinical trials
2005
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

Executive briefingUpdating summary…Momentum: Low
Key developments
  • 2 clinical trials expected to report results, the earliest in Q4 2026.
Upcoming Milestones
Major developments
Upcoming trial readoutHigh impact
A Phase I Study of MozobilTM in the Treatment of Patients With WHIMS
Results expected Q4 20262026-07-02
Upcoming trial readoutImportant
Efficacy of Luspatercept In Clonal Cytopenias of Uncertain Significance
Results expected Q1 20272026-03-24
Clinical Milestones2View
Results expected 2
Activity timeline2

Clinical trials

5 sponsors · 0 new · 0 completed in the last 12 months (net +0)

The current development programme across all trial phases.

Clinical programme
5
All trials
2
Active
2
Late-stage
3
Completed
Recruiting

A Phase I Study of MozobilTM in the Treatment of Patients With WHIMS

Phase 1/2 · Recruiting · National Institute of Allergy and Infectious Diseases (NIAID)

Efficacy of Luspatercept In Clonal Cytopenias of Uncertain Significance

Phase 2 · Recruiting · Weill Medical College of Cornell University

Research activity

2 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Publications over time
19662005
Major themes3
  • Leukocyte Count1
  • Leukopenia1
  • Lymphocytes1
Leading journals2
  • Annals of internal medicine1
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology1
Leading researchers8
  • Antón A1
  • Bodey GP1
  • Buckley M1
  • Chan S1
  • Cognetti F1
  • Conte P1
  • Extra JM1
  • Freireich EJ1
Affiliations (unnormalised)1
  • Institut Gustave-Roussy1

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

A decrease in the number of LEUKOCYTES in a blood sample below the normal range (LEUKOCYTE COUNT less than 4000).

Identifiers
MeSHLeukopenia
References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.